Similarly, the percentage of PD-1+ CD8+ T-cells and PD-L1+ MOC1 tumor cells, as well as the percentage of MOC1 tumor cells that were positive for major histocompatibility complex (MHC) class I H-2Kb/Db was increased but not at a significant level (Fig. 4C). This evidence concerns the gene CD8A and neoplasm.